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Summary 
Lipopolysaccharide (LPS), a highly conserved component of the outer membrane of gram-negative 
bacteria, stimulates macrophages to release various cytokine and eicosanoid mediators of the im- 
mune response. The mechanism by which LPS stimulates these cells is poorly characterized. One 
of the most rapid LPS-stimulated events is the phosphorylation  and activation of the p42 and 
p44 isoforms of mitogen-activated  protein  (MAP) kinase.  We wished to examine the role of 
MAP kinase in LPS-induced signaling  in murine  macrophages by activating MAP kinase in- 
dependently of LPS.  An expression vector encoding a Raf-l:estrogen receptor  (ER) chimeric 
protein was transfected into the murine macrophage cell line RAW 264.7.  Activation of this 
chimeric protein (ARaf-I:ER) by estradiol resulted in rapid and prolonged activation of MAP 
kinase, as expected from previous results implicating Raf-1 as an upstream activator of this sig- 
naling cascade.  LPS stimulation induced accumulation of MAP kinase phosphatase 1 messenger 
RNA, whereas ARaf-I:ER activation did not, perhaps accounting for the more prolonged acti- 
vation of MAP kinase seen in response to ARaf-I:ER activation. Similarly, activation of DNA 
binding by the transcription  factor, nuclear factor (NF) KB, as assessed by electrophoretic mo- 
bility shift assay, occurred in response to LPS stimulation  but not in response to ARaf-I:ER 
activation or phorbol myristate acetate (PMA) stimulation. Using an enzyme-linked immunosorbent 
assay for murine tumor necrosis factor o~ (TNF-ot), we found that LPS and PMA stimulation 
and ARaf-I:ER activation induced secretion of TNF-c~, although the amount of TNF-cr secreted 
in response to ARaf-I:ER activation and PMA stimulation was "~20-fold less than that secreted 
in response to LPS. Correspondingly, accumulation of TNF-ot messenger RNA was weakly in- 
duced by ARaf-I:ER activation or PMA stimulation,  whereas strong induction was noted in 
response to LPS. These results suggest that Raf-1 or PMA activation of MAP kinase in murine 
macrophages is sufficient for a small amount of TNF-ot production and secretion in the absence 
of NF-KB activation, but LPS stimulation  involves additional signaling  events, such as NF-KB 
activation,  that  augment  the response seen with  activation of MAP kinase alone. 
T 
he  host's  response  to  infection  with  gram-negative 
bacteria is initiated by exposure to LPS, a major compo- 
nent of the bacterium's outer membrane and a potent acti- 
vator of macrophages (1, 2). Subsequent production and re- 
lease  of large  numbers  of immunoregulatory  molecules, 
including TNF-ot, IL-1, IL-6, and arachidonic acid metabo- 
lites,  then recruit  and activate other immune  cells  to help 
fight the infection (3, 4). Additionally, LPS stimulation  of 
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IFN-3,-primed macrophages induces them to acquire bacte- 
ricidal and tumoricidal activity (5, 6). Systemic stimulation 
of these immune reactions may culminate in septic shock, 
a major cause of morbidity and mortality  each year. 
The mechanism by which LPS activates macrophages is 
still poorly understood. At physiological concentrations, LPS 
binds to the serum protein LPS-binding protein.  This com- 
plex then interacts with CD14 on macrophages or neutro- 
phils (7-11). As CD14 is a glycosyl phosphatidylinositol-linked 
protein, it is unclear how LPS binding to it leads to intracel- 
lular signaling events. Nonetheless, phosphorylation of var- 
ious proteins on tyrosyl residues is the most rapid intracel- 
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(12, 13). Inhibitors of  protein tyrosine phosphorylation block 
the secretion of cytokines and the generation of eicosanoids 
(13-17),  arguing for the importance of this signaling event. 
Among the most prominent tyrosine-phosphorylated pro- 
teins in LPS-stimulated macrophages are the p42 and p44 iso- 
forms of mitogen-activated protein (MAP) 1 kinase (13, 18, 
19). MAP kinases are a family of serine/threonine protein 
kinases  that participates in signaling pathways initiated by 
many extracellular stimuli. In Sacckaromyces cerevisiae, for ex- 
ample, distinct MAP kinase pathways are involved in medi- 
ating the pheromone response, cell wall biosynthesis, and os- 
moregulation (20, 21). In multicellular organisms, the MAP 
kinase cascade also plays an important role in mediating sig- 
naling events. MAP kinase activation has been implicated in 
the activation of the transcription factors p62 ~r and nuclear 
factor (NF)-IL-6 (22,  23) and of cytoplasmic phospholipase 
A2,  which catalyzes  the release  of arachidonic acid from 
membrane phospholipid (24). 
To examine the role of MAP kinase activation in LPS sig- 
naling, we wished to determine whether activation of MAP 
kinase by a means independent of LPS would mimic the down- 
stream biologic events seen with LPS stimulation. In this re- 
port, we show that activation of a regulatable form of Raf-1 
in murine macrophages resulted in strong activation of p42 
and  p44  MAPK but  only modest  TNF-ol  messenger  RNA 
(mRNA) accumulation and protein secretion. Moreover, LPS 
stimulated accumulation of  MAP kinasepkospkatase  I (MKP-I) 
mRNA and activation of the transcription factor NF-KB, 
whereas Raf-1 did not. These results suggest that LPS in- 
duces additional signaling events, such as NF-KB activation, 
that augment the response seen with activation of MAP ki- 
nase alone. 
Materials  and Methods 
Materials and Antibodies.  LPS (Salmonella minnesota R595) was 
purchased from List Biological Laboratories, Inc. (Campbell, CA) 
and  prepared as  a  5-mg/ml suspension in  pyrogen-free H20. 
fl-Estradiol and myelin basic protein (MBP) were purchased from 
Sigma Chemical Co. (St. Louis, MO). ICI 164,384, which binds 
and inhibits the function of native estrogen receptors, was a gift 
of  Alan Wakeling  (Zeneca  Pharmaceuticals,  Cheshire,  UK). Estradiol 
and ICI 164,384 were stored as 1-mM stock solutions in ethanol 
at  -20~  G418 was purchased from Gibco BRL (Gaithersburg, 
MD). Anti-p42  ~LAPx mAb (1B3B9) was a gift from Dr. Michael 
Weber (University of Virginia, Charlottesville, VA). Anti-TNF-c~ 
antibody was purchased from Genzyme Corp. (Cambridge, MA), 
and anti-bcB-c~ and anti-p44  ~PK antibodies were procured from 
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Sheep anti- 
mouse IgG conjugated to horseradish  peroxidase  and the enhanced 
cherailuminescent  detection kit for immunoblotting were purchased 
from Amersham Corp.  (Arlington Heights, IL). 
Cell Culture, Electroporation, Stimulation,  and Cell Lysis.  The 
Abelson murine leukemia virus-transformed macrophage cell line 
1Abbreviations used in this paper: EMSA, electrophoretic mobility shift 
assay; ER, estrogen  receptor; MAP, mitogen-activated  protein; MBP, my- 
din basic  protein; MKP-1, MAP kinase  phosphatase 1; mRNA, messenger 
RNA; NF, nuclear factor. 
RAW 264.7 (American Type Culture Collection, Rockville, MD) 
was cultured in DME containing 10% heat-inactivated fetal bo- 
vine serum (containing <0.6 endotoxin U/ml) and 2 mM gluta- 
mine at 37~  in a 5% CO2/air mixture. A truncated, oncogenic 
form of human p74  P~fl fused to the hormone-binding domain of 
the HE14 allele of the human estrogen receptor (ARaf-I:ER) was 
cloned into the replication-defective  retrovirus pLNCX vector that 
encodes G418 resistance, as previously  described (25). This expres- 
sion vector was transfected into RAW 264.7 cells by electropora- 
tion, using a Gene Pulser (Bio-Rad Laboratories, Richmond, CA) 
at settings of  350 V and 500 #F. G418-resistant  clones  were screened 
for expression  of  the ARaf-I:ER protein by immunoblotting, using 
a polyclonal antiserum that recognizes the hormone-binding do- 
main of the human estrogen receptor (gift of  Dr. S. Robbins, G. W. 
Hooper Foundation, University of California, San Francisco,  CA). 
Transfectants  were maintained in the above medium supplemented 
with 1.5 mg/ml G418. 
To examine  cellular  responses, 1-2  x  106 cells were seeded onto 
six-well  plates (Costar Corp., Cambridge,  MA) in 1.5 ml of  medium. 
Parental RAW 264.7 cells were cultured '~16 h to reach 80% 
confluency.  RAW:ARaf-I:ER cells, which grow more slowly than 
the parental cells when maintained in G418 at 1.5 mg/ml, were 
cultured for 2 d to reach "~80% confluency.  After stimulation, cells 
were washed in situ with ice-cold PBS containing 1 mM sodium 
orthovanadate (Na3VO4) and then lysed on ice in 0.2 ml of lysis 
buffer containing 20 mM Tris (pH 7.9), 137 mM NaCI, 5 mM 
Naz EDTA, 10% (vol/vol) glycerol, 1% (vol/vol) Triton X-100, 
I mM PMSF, I mM aprotinin, I mM leupeptin, 1 mM Na3VO4, 
1  mM  EGTA, 10  mM  sodium  fluoride,  1 mM  tetrasodium 
pyrophosphate, and 100 #M fl-glycerophosphate.  Insoluble mate- 
rial was removed  by centrifugation at 12,000g, and soluble protein 
was stored at -80~  or used immediately. Protein concentrations 
of the lysates  were determined by using the BCA protein assay  kit 
(Pierce, Rockford, IL). 
Electwphoresisandlraraunoblotting.  Protein  samples  were prepared 
for electrophoresis as previously  described (25). Samples  were sepa- 
rated on 12.5% SDS-PAGE  containing an acrylamide/bis-acrylamide 
ratio of 120:1 and transferred to nitrocellulose. The nitrocellulose 
membranes were blocked  by incubation in Tris-buffered  saline  con- 
taining 0.5%  (vol/vol) NP-40 and 5% nonfat dry milk. Subse- 
quently, the membranes  were incubated with anti-MAP kinase an- 
tibody and washed  in Tris-buffered  saline  containing  0.5% (vol/vol) 
NP-40. Antigen-antibody complexes were visualized  by incubating 
the membranes with 1:10,000 diluted sheep anti-mouse IgG anti- 
body coupled to horseradish peroxidase and using the enhanced 
chemiluminescent detection system. 
In-gel MAP Kinase Assay.  MAP kinase activity was assessed 
by the in-gel kinase assay,  wherein MBP, an MAP kinase substrate, 
was copolymerized  into the polyacrylamide  gel (25, 26). After reso- 
lution of  lysate  proteins  by SDS-PAGE through the MBP-containing 
gel, the gel was subjected to a denaturation/renaturation  proce- 
dure, after which it was incubated in the presence of ~/-[32p]ATP 
to allow phosphorylation of MBP, washed extensively,  dried, and 
exposed to x-ray film (25, 26). 
RNA Isolation and Northern Blot Analysis.  Total  RNA was ex- 
tracted from cells  by the acid phenol method as described  (27), with 
the exception  that only one isopropanol  precipitation  was performed. 
RNA (2.0-2.5 #g/lane) was resolved by dectrophoresis through 
1.2% agarose gels containing 2 M formaldehyde, buffered with 
5 mM Hepes, pH 7.0, transferred  to membranes  (GeneScreen;  New 
England Nuclear, Boston, MA), and cross-linked  to the membranes 
by UV irradiation with an irradiator (Stratalinker 1800; Stratagene, 
La Jolla, CA). Specific RNA was detected by probing the mem- 
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heim Corp., Indianapolis, IN) 3zP-labeled cDNA probes. Hybrid- 
ization was performed  at 42~  in buffer  containing 50% formamide, 
1 M NaC1, 1% SDS, 10% dextran sulfate, and 125 #g/ml dena- 
tured salmon sperm DNA. Filters were washed in 0.1  x  SSC and 
1% SDS at 65~  to remove nonspecific  binding of the probe. To 
strip off probe for subsequent reprobing, blots were boiled for 10 
rain in 0.1% SDS. To ensure that similar amounts of RNA were 
loaded  in each  lane, the stripped  blots were reprobed  with the cDNA 
of the constitutively expressed gene GAPDH (28). 
The probe for MKP-I (3CH134) was made from the EcoRI frag- 
ment of3CH134  BALB/c  mouse DNA, obtained from Dr. D. Na- 
thans (Johns Hopkins University, Baltimore, MD) (29). The probe 
for the murine TNF-Qt  gene was a gift from Dr. S. Reiner (Univer- 
sity of California, San Francisco) (30). 
NFqcB Assay.  For the assay  of NF-gB activation, ,,o2-4 x  106 
ceils were seeded onto  100-mm plates and grown  to 70--80% 
confluency.  Preparation of  nuclear extracts for measurement of  NF- 
KB DNA binding activity by electrophoretic mobility shift assay 
(EMSA) were performed as described by Kitchens et al. (31). The 
NF-KB oligonucleotide  containing the routine immunoglobulin KB 
enhancer sequence (32) 5' TCAGAGGGGACTTTCCGAGAGGT 
3~ 3' TCCCCTGAAAGGCTCTCCAGCT 5' was prepared by an- 
nealing complementary synthetic oligonucleotides. This binding 
site was labeled with ot-[32p]dCTP  using the Klenow fragment of 
Escherichia coli DNA polymerase I (New England Biolabs, Inc., 
Beverly, MA). Competition experiments  were performed with var- 
ious amounts of  unlabeled double-stranded  olignnucleotide  or with 
an oligonucleotide that contains mutations in the binding motif 
and subsequently does not bind NF-KB (33). The mutant KB oli- 
gonucleotide sequence was as follows: 5' TCAGAGCTCACTTT- 
CCGAGAGGT 3'. Protein-DNA complexes were then analyzed 
by PAGE (4%) in 0.Sx  tris-borate EDTA (34). 
TNF.~ ELISA.  Murine TNF-o~ ELISA kits were purchased 
from PerSeptive  Diagnostics  (Cambridge, MA) and BioSource  Inter- 
national (Camariilo, CA). 50-#1 aliquots of cell medium from un- 
treated cells or from cells stimulated with LPS, estradiol, ICI 
164,384, or PMA were analyzed according to the instructions that 
accompanied  the kits. Each sample  was incubated  for the same  length 
of time and tested in duplicate. 
Results 
ARaf-I:ER Activation Results in Phosphorylation and Activa- 
tion of  MAP Kinase.  Stimulation of macrophages with LPS 
rapidly results in the tyrosine phosphorylation of several pro- 
teins, including the p42  and p44 isoforms of MAP kinase 
(13, 18, 19). In addition, the activity of these MAP kinases 
is greatly increased  by LPS treatment. To gain insight into 
the role of MAP kinase in mediating the response to LPS 
in macrophages, we sought to activate MAP kinase indepen- 
dently of LPS. One mechanism by which receptors  activate 
MAP kinase is through stimulation of Ras, which in turn 
activates the serine/threonine-specific protein kinase Raf-1. 
Therefore, we made use of an estradiol-dependent form of 
Raf-1, ARaf-I:EK. Addition of estradiol to 3T3 cells expressing 
ARaf-I:EK leads  to rapid activation of the fusion protein, 
MEK, and p42/p44 MAP kinases,  and ultimately to onco- 
genic transformation (25). The RAW 264.7 macrophage cell 
line, which responds well to LPS, was stably transfected with 
the expression vector, and transfectants were screened for ex- 
pression of the ARaf-I:ER protein. 
Transfectant cells (RAW:ARaf-I:ER) and parental RAW 
264.7 cells were stimulated for 15 min with estradiol (1 #M), 
ICI 164,384 (1/~M), LPS (1/~g/ml), or a buffer control (0.1% 
ethanol vol/vol). Triton X-100-soluble  proteins were obtained 
from the cells, resolved by SDS-PAGE, and immunoblotted 
with an anti-p42 ~K  antibody. Phosphorylation of p42 M~pK 
is accompanied by reduced electrophoretic mobility upon SDS- 
PAGE. The electrophoretic shift of p42  ~PK occurred in re- 
sponse to LPS stimulation in the parental cells and in response 
to estradiol,  ICI 164,384, or LPS stimulation in RAW:ARaf- 
I:ER cells (Fig.  1 and additional data not shown). This du- 
ration of LPS stimulation led to the phosphorylation of vir- 
tually 100%  of p42  stAPK. Activation of ARaf-I:ER for the 
same duration led to phosphorylation of ,,o60% of p42 ~g. 
Tyrosine phosphorylation of the shifted form of p42  tc~Pg 
was verified by immunoblotting with the 4G10 antiphos- 
photyrosine  antibody  (data  not  shown).  A  similar  elec- 
trophoretic shift of p44  M^vK was seen with blotting with 
anti-p44 antibody (data not shown). Transfected RAW 264.7 
cells that were resistant to G418 but did not express detect- 
able levels of the ARaf-I:EK chimera showed no activation 
of p42  M~K in response to estradiol or ICI 164,384 (data not 
shown). 
To verify that the shifted form of p42/p44  MAP kinase 
correlated with activation of the enzyme and to analyze the 
kinetics of this activation, RAW:ARaf-I:ER cells were treated 
with LPS, estradiol, or ICI 164,384  for various lengths of 
time. Triton X-100-soluble proteins were analyzed by an in- 
gel MAP kinase activity assay (Fig. 2). In this assay, the ac- 
tivity of the p42 and p44 MAP kinase isoforms is reflected 
by the amount of phosphorylation of MBP, an MAP kinase 
substrate that is incorporated into the gel, at the position 
in the gel where these MAP kinases migrate. As previously 
demonstrated for the parental RAW 264.7 cells  (13), LPS 
stimulation of RAW:ARaf-I:ER cells, as well as stimulation 
of ARaf-I:ER by estradiol or ICI 164,384, resulted in activa- 
tion of the p42 and p44 isoforms of MAP kinase. LPS stimu- 
lation ofp42/p44 was noted after 10 min of stimulation, was 
maximal by 15 to 20 rain, and declined between 1 and 4 h 
(Fig.  2 A  and additional data not shown).  Stimulation of 
ARaf-I:ER by estradiol or ICI 164,384 resulted in a similar 
onset of activation, but this activation was prolonged and 
persisted for at least  30 h  (Fig.  2, A  and B). 
Figure  1.  Shift  in electrophoretic  mobility  of p42  MApK  upon ARaf-I:ER 
activation or LPS stimulation.  50 #g of detergent-sohble  proteins from 
unstimulated  (US) RAW:ARaf-I:EK  or parental RAW 264.7 ceUs or from 
cells treated for 15 rain with estradiol  (E2; 1 #M), LPS (1 #g/ml), and 
control (C; ethanol  0.1% vol/vol)  were separated on 12.5% SDS-PAGE, 
transferred to  nitrocellulose, and immunoblotted with  1B3B9 anti- 
p42  M^vg antibody, p42 refers to p42  M^PK, and pp42 indicates  the phos- 
phorylated  form of p42  MApK, which  is a more slowly  migrating  form of 
p42  MAPK. 
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in response to LPS, estradiol, or ICI 164,384. 50/~g of detergent-soluble 
protein from unstimulated (time 0) RAW:ARaf-I:ER cells or from these 
cells treated with LPS (1/~g/ml),  estradiol (E2; 1 #M), or ICI 164,384 
(1  /~M) for  varying lengths  of time were electrophoresed into  SDS- 
polyacrylamide  gels containing MBP. After denaturation and renaturation 
of proteins, the kinase activity was determined in situ by phosphorylation 
of the incorporated MBP. pp42 and pp44 indicate the activated p42 and 
p44 isoforms of MAP kinase, respectively.  Please note that B is a longer 
exposure than A. 
Sustained Activation of MAP Kinase by zlRaf-I:ER May Be 
Due to the Absence of Phosphatase Induction.  The prolonged 
phosphorylation  and  activation  of  p42  MApK observed  in 
estradiol-treated  RAW:ARaf-I:ER  cells suggested  that  the 
normal inactivation of the MAP kinase pathway seen in LPS- 
treated cells is not occurring. It is thought that inactivation 
of MAP kinase occurs by removal of the activating phosphates 
by  phosphatases.  MKP-I  or  3CH134  is  a  growth  factor- 
inducible gene that encodes a dual specificity phosphatase that 
can dephosphorylate and inactivate MAP kinase in vitro and 
in vivo (35, 36).  In RAW:ARaf-I:ER  cells, MKP-1 mRNA 
was  induced  in  response  to LPS stimulation  (Fig.  3).  LPS 
stimulation ofMKP-1 mRNA was detected at 30 rain, peaked 
at 2 h, and declined thereafter. In contrast, activation of the 
ARaf-I:ER  fusion protein did not induce the MKP-1  gene 
in  these cells.  Similarly,  the MKP-1  gene was  not  induced 
in response to PMA  stimulation.  Activation of ARaf-I:ER 
in 3T3 ceils also does not lead to induction ofMKP-1 mRNA 
expression (McCarthy,  S.,  and M.  McMahon,  unpublished 
Figure 3.  Induced  expression of the MKP-1 gene in RAW:ARaf-I:ER 
cells. Total RNA was isolated from unstimulated (US) RAW:ARaf-I:ER 
cells or from cells stimulated for varying lengths of time with estradiol 
(1 ~M), LPS (1 #g/ml), or PMA (100 nM), and then subjected  to Northern 
blot analysis (~2.0-2.5 #g RNA per lane). The filter was probed with 
an MKP.I cDNA clone, stripped, and then reprobed with GAPDH to 
verify similar loading of RNA in each lane. 
Figure  4.  NF-KB  activation in response to LPS or estradiol. EMSA was 
performed on 5 #g of nuclear extracts from parental or RAW:ARaf-I:ER 
cells (pLNC2). The parental RAW 264.7 cells were either unstimulated 
(US) or treated with LPS (1/~g/ml) for I h. EMSA was then performed 
using the 32p-labeled  KB oligonucleotide. Competition experiments were 
done with the addition of unlabeled wild type (I.VT  r,B) or mutated oli- 
gonucleotide (rout r.B) as indicated. RAW:ARaf-I:ER cells were either 
unstimulated (US) or stimulated with LPS (1 #g/ml) or estradiol (E2; 
1/~M) for I h. The positions of the oligonucleotide  complex and the free 
oligonucleotide are indicated. 
observations).  The failure of the ARaf-I:ER protein to in- 
duce MKP-1 expression may contribute to the prolonged ac- 
tivation of MAP kinases seen upon activation of this protein. 
Stimulation of  A Raf1:ER Does Not Result in NF-KB Activa- 
tion.  Since  activation  of ARaf-I:ER  in  RAW  264.7  cells 
resulted in the rapid and near-complete activation of MAP 
kinase,  it  was  of interest  to  assess  whether  activation  of 
p42  M^PK and  p44  M^vK by  the  ARaf-I:ER  fusion  protein 
mimics LPS with  respect to downstream  events.  NF-~B is 
thought to play a central role in LPS-mediated transcriptional 
regulation.  In RAW 264.7 cells, LPS has been shown to in- 
duce nuclear translocation of the NF-~B 50-kD subunit and 
activation of reporter constructs using NF-KB-binding sites 
(33, 37, 38). Moreover, there is one report that p74  ~-1 may 
promote NF-KB activity via phosphorylation  and inactiva- 
tion of I~B-o~ (39). We therefore wished to test whether ac- 
tivation of ARaf-I:ER would lead to activation of NF-KB. 
RAW:ARaf-I:ER  cells were stimulated  for up to 2 h  with 
estradiol, LPS, or PMA, and nuclear extracts were prepared. 
These extracts were tested for the presence of NF-KB DNA 
binding  activity by EMSA.  As  shown  in Fig.  4,  LPS acti- 
vated NF-~B binding activity in these cells, whereas estradiol 
did not. PMA stimulation of RAW 264.7 and RAW: ARaf- 
I:ER cells also did not lead to an increase in NF-~B DNA 
binding activity (data not shown). The LPS-inducible com- 
plex was specifically competed away by an unlabeled oligo- 
nucleotide containing the ~B-binding site, but not by an un- 
labeled oligonucleotide with mutations in this KB site. These 
results demonstrate that the LPS-inducible complex is specific 
for KB-like DNA  sites.  Moreover, LPS stimulation resulted 
in the transient decrease in I~B-ol protein that is noted with 
NF-KB activation (40), whereas no change in I~B-ot protein 
level was seen with ARaf-I:ER activation by estradiol (data 
not  shown). 
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ARaf-I:ER, we found no evidence that activation of ARaf- 
I:ER had any effect on NF-KB binding activity or transcrip- 
tional activation (Samuels, M.  L., and M.  McMahon,  un- 
published observations). Furthermore, immune complexes of 
ARaf-I:ER, which phosphorylated MEK, did not phosphory- 
late a purified GST-IKB-(~ fusion protein (Samuels,  M.  L., 
S. Gerondakis, and M. McMahon, unpublished observations). 
Activation of ARaf-l:ER  Results in a Low Level of TNF-ol 
Secretion.  LPS stimulation of macrophages leads  to secre- 
tion of many cytokines, among the most important of which 
is TNF-ol. LPS regulates TNF-o~ expression at both the tran- 
scriptional and translational levels (41-44). LPS has been shown 
to induce TNF-oe expression at the transcriptional level at 
least in part via the NF-KB-binding sites in the 5' promoter 
region of the gene (41).  Using  an ELISA to  measure the 
amount of TNF-cr protein secreted into the cell medium, 
we found that estradiol, ICI 164,384, PMA, or LPS stimula- 
tion induced secretion of TNF-ol by RAW:ARaf-I:ER cells, 
although the amount of TNF-c~ secreted in response to es- 
tradiol, ICI 164,384, or PMA stimulation was 20-fold less 
than that  secreted in response to LPS stimulation (Fig.  5, 
A  and B).  The kinetics of TNF-ol production was similar 
in each case, and secretion was seen as early as 30 rain after 
stimulation. The levels of secreted TNF-~ depicted in Fig. 
5 are representative of at least two experiments for each stim- 
ulation condition. TNF-ol secretion was not increased in re- 
sponse to estradiol or ICI 164,384 in either the RAW 264.7 
cells or the G418-resistant transfected cells that did not ex- 
press the ARaf-I:ER chimera (Fig. 5 C). In the RAW:ARaf- 
I:ER cells, ethanol (0.1%) did not induce TNF-c~ secretion 
(data not shown). LPS-induced secretion of TNF-ol at 3 and 
6 h was confirmed by immunoblotting with anti-TNF-ol anti- 
body (data not  shown). 
To test whether this difference in TNF-ol secretion between 
LPS and estradiol or PMA stimulations was reflected at the 
mRNA level, Northern blot analysis of RNA from RAW: 
ARaf-I:ER cells was performed. A  strong induction of the 
TNF-ol gene in response to LPS stimulation was demonstrated, 
whereas only weak inductions in response to ARaf-I:ER ac- 
tivation or PMA  stimulation were detected (Fig.  6).  This 
weak induction over background was confirmed by quanti- 
tation on a Phosphorlmager (Molecular Dynamics, Sunnyvale, 
CA) and is representative of two experiments. Thus,  acti- 
vated  Raf-1  was  able  to  induce  accumulation  of TNF-ol 
mR,  NA,  but considerably less efficiently than LPS. 
Discussion 
LPS stimulation of macrophages results in a rapid increase 
in protein tyrosine phosphorylation and activation of the p42 
and  p44  isoforms of MAP  kinase.  We have introduced a 
regulatable form of Raf-1 that can activate MAP kinase in- 
dependently of LPS into routine macrophages, allowing us 
to evaluate possible downstream events. In RAW 264.7 mac- 
rophage cells, as previously reported in fibroblasts, estradiol- 
induced activation of the ARaf-I:ER chimeric protein resulted 
in rapid and prolonged phosphorylation and activation of the 
Figure  5.  Induced  production  of secreted  TNF-o~  in RAW:ARaf-I:ER 
cells. 50-~1 aliquots  of  medium  from  untreated  RAW:ARaf-I:ER  cells  (time 
0) or from  cells  stimulated (A) with LPS (1/~g/ml), estradiol  (17.2; 1/tM), 
or ICI 164,384 (1/~M); or, in a different  experiment  (B), with LPS, es- 
tradiol, or PMA (100  nM); were  analyzed  for TNF-ot  secretion  by ELISA. 
All samples were incubated for the same length of time, so that the 0 
time point reflects  an unstimulated control. The samples were tested in 
duplicate. (C) 50-#l  aliquots of medium  from  unstimulated (US) parental 
RAW 264.7 cells or G418-resistant transfected  cells that do not express 
ARaf-I:ER. ~MLV2), or from cells stimulated with LPS (1/~g/ml), es- 
tradiol (E2; 1 #M), or ICI 164,384 (1/~M), were analyzed  for TNF-(x 
secretion  by ELISA. The RAW 264.7 cells were stimulated for 3 h, and 
the pMLV2 cells were stimulated for 2 h. 
151  Hambleton  et al. Figure 6.  Accumulation  of TNF-e~  mRNA in response to stimulation 
of  RAW:ARaf-I:ER  cells. Total RNA was isolated  from  uustimulated  (US) 
RAW:ARaf-I:ER  cells  or from cells  stimulated  for varying  lengths of  time 
with estradiol (E2; 1/~M), LPS (1/zg/ml), PMA (100 nM), or ethanol 
control (C; 0.1% vol/vol; 1-h treatment) and then subjected  to Northern 
blot analysis (~2.0-2.5/zg RNA per lane). The filter was probed with 
a TN/Z~ cDNA done, stripped, and then reprobed  with GAPDH  to verify 
similar loading of RNA in each lane. 
p42/p44  MAP kinases.  This was evident by mobility shift 
on  SDS-PAGE,  which  is  characteristic  for  p42/p44  mpK 
phosphorylation and activation, and by an increase in MAP 
kinase activity as assessed by an in-gel protein kinase activity 
assay. 
One interesting  feature of the activation of MAP kinase 
by ARaf-I:ER is the prolonged activation in comparison to 
that seen with LPS. The onset ofp42/p44 MAP kinase acti- 
vation by ARaf-I:ER was similar to LPS stimulation.  How- 
ever,  LPS treatment  led to a strong  transient  activation  of 
MAP kinase followed by a low level of continued activation. 
In contrast,  activation  of the ARaf-I:ER chimeric  protein 
resulted  in  a strong  sustained  activation  of p42/p44  MAP 
kinase.  There are many mechanisms  that  could shut down 
the LPS response, but one interesting possibility involves the 
regulation of phosphatases that dephosphorylate and thereby 
inactivate MAP kinases.  In the RAW:ARaf-I:ER cells,  the 
immediate early response gene MKP-1 is induced in response 
to LPS stimulation, but not in response to activation of the 
ARaf-I:ER chimeric protein with estradiol, suggesting that 
MKP-1 induction is not downstream of Raf-1 or MAP ki- 
nase  activation.  Thus,  the expression of MKP-1 in macro- 
phages is not a result of direct feedback of MAP kinase ac- 
tion.  Rather,  LPS  stimulation  induces  this  MAP  kinase 
inhibitor  via a distinct  signaling  route. 
After characterizing the activation of MAP kinase by ARaf- 
I:ER, we wished to examine its effect on downstream events. 
Activation  of the  transcription  factor NF-KB is implicated 
in  the induction  of a number of genes by LPS.  This  tran- 
scription factor is composed of two subunits of 50 and 65 
kD, which are sequestered in the cytoplasm in  an inactive 
state by ItcB. Upon activation, IgB undergoes phosphoryla- 
tion and degradation,  and the NF-KB heterodimer  translo- 
cates into the nucleus, where it binds to DNA and activates 
transcription (45, 46). In agreement with other reports (38), 
LPS stimulated increased DNA binding by NF-KB in RAW 
264.7 cells. In contrast, activation of the ARaf-I:ER chimera 
with estradiol did not activate NF-KB detectably. This ob- 
servation is contrary to a recent report by Li and Sedivy, in 
which it was found that v-rafphosphorylated  IKB and acti- 
vated NF-KB nuclear translocation.  Moreover, in their tran- 
sient transfection experiments, v-rafinduced transcription via 
an NF-KB-based promoter in fibroblasts (39). The failure of 
ARaf-I:ER to activate NF-r,B in RAW 264.7 cells could reflect 
the different means of activating Raf-1 in our experiments 
versus the experiments of Li and Sedivy. Alternatively, there 
could be some difference in intraceilular  components between 
macrophages and fibroblasts. We also did not observe activa- 
tion of NF-gB when RAW 264.7 cells were stimulated with 
PMA, in agreement with other reports (33, 37).  As PMA 
is a potent activator of MAP kinase in RAW 264.7 calls (13), 
activation of MAP kinase does not correlate with NF-IcB ac- 
tivation.  Our results  suggest  that  neither  Raf-1 nor  MAP 
kinase is responsible for activating NF-KB in macrophages, 
and  that  LPS does this  via a different  signaling  pathway. 
NF-KB activation is thought to be critical for TNtZol gene 
expression in macrophages stimulated by LPS (41, 42, 44). 
While LPS stimulates strong TNF-c~ production and TNF-cx 
mRNA accumulation, activation of the ARaf-I:ER chimera 
or stimulation with PMA gave smaller ('~20x  less by ELISA) 
but clearly positive TNF-c~ responses. The most straightfor- 
ward interpretation of these results is that activation of MAP 
kinase by Raf-1 or PMA in murine macrophages is suf~dent 
for a smaU level of TNF-c~ secretion in the absence of NF-gB 
activation.  In contrast, LPS activates both MAP kinase and 
NF-gB, which may cooperate to give the high level of TNF-ot 
secretion seen upon stimulation  in this way. Alternatively, 
other signaling events triggered by LPS may play critical roles 
instead of or in addition to NF-gB and MAP kinase.  Simi- 
larly,  Raf-1 could be activating other proteins,  in addition 
to MAP kinase,  that  have not yet been identified but that 
mimic LPS and PMA stimulation with respect to downstream 
events. 
The antiestrogen ICI 164,384 binds and inhibits the func- 
tion of native estrogen receptors (47-49) and is a potent acti- 
vator of the ARaf-I:ER chimeric protein. The ability of this 
compound to induce activation of MAP kinase and secretion 
of TNF-o~ in cells expressing ARaf-I:ER argues against the 
possibility that endogenous estrogen receptors play a role in 
these signaling processes, and it ascribes that function to the 
activation  of Raf-1 in  these ceUs. 
The mechanism by which LPS activates MAP kinase is not 
yet completely established.  In vertebrates, the p42 and p44 
isoforms of MAP kinase can be activated by at least two sep- 
arate pathways that converge at the level of MAP kinase ki- 
nase  or MEK.  One  pathway  involves ligand-activation  of 
receptor tyrosine kinases with  the  sequential  activation  of 
Ras,  Raf, MEK,  and MAP kinase.  This pathway has  been 
established by a variety of biochemical experiments (20, 21) 
and by genetic studies of developmental mutants of Drosophila 
melanogaster and Caenorhabditus elegans (50).  The  existence 
of a second pathway was suggested by studies in yeast, and 
a vertebrate homologne of the yeast gene product STE  11, 
called MEK kinase,  has been cloned and found capable of 
activating MEK (51). 
In  human  monocytes,  LPS  stimulation  increases  Ras 
GTP/GDP exchange (52), and LPS treatment  of BAC-1.25 
macrophages leads to activation of Raf-1, MEK,  and MAP 
kinase, as well as phosphorylation of the transcription factor 
152  MAP Kinase and LPS-induced Signaling Elk-1 (53).  Experiments with a dominant negative form of 
Ras also  indicate that LPS may activate MAP kinase and 
TNF-cr production via the Ras/Raf-1 pathway in RAW 264.7 
cells (54). In one contrary report, LPS did not activate Ras, 
but it did seem to act via Raf-1 (55). Thus, evidence to date 
largely supports the possibility that LPS activates Raf-1 and 
subsequently MEK and MAP kinase. We have used the ARaf- 
I:ER chimera in macrophages to provide a method for ac- 
tivating MAP kinase. These experiments have revealed that 
Raf-1 and MAP kinase activation stimulate only some down- 
stream events seen with LPS stimulation. These results sug- 
gest that LPS stimulation of macrophages activates  at least 
two signal transduction pathways, one involving MAP ki- 
nase and a second that is independent of the MAP kinase 
cascade. 
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